Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

11/2/2012 (2 years ago)

Catholic Online (www.catholic.org)

Alemtuzumab is used most frequently in cancer, leukemia patients

Alemtuzumab is a new drug is the "most effective" treatment for relapsing-remitting multiple sclerosis. Researchers at the University of Cambridge say that alemtuzumab, a cancer drug, which wipes out and resets the immune system, has better results than other options. The down side? There is new concern that the drugs company that manufactures the medication is about to increase the cost of the drug as a result.

'There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems,' an editorial in the medical journal the Lancet warns.

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

11/2/2012 (2 years ago)

Published in Health

Keywords: Alemtuzumab, multiple sclerosis, leukemia, cancer, price hike


LOS ANGELES, CA (Catholic Online) - Around 100,000 people in the United Kingdom have multiple sclerosis. When the condition is diagnosed, the majority will have a form of the disease know as relapsing-remitting MS. In this strain of the condition, the symptoms can almost disappear for a time, before suddenly returning.

Alemtuzumab has shown benefits for MS in small studies. Typically used for leukemia patients, a blood cancer, controls the excess production of white blood cells. In MS patients, the dose eliminates the immune cells entirely, forcing a new immune system to be built from scratch which should not attack the nerves.

Two test trials compared the effectiveness of alemtuzumab with a first-choice drug, interferon beta-1a.

One compared the effectiveness in patients given the drug after being diagnosed, the other looked at patients given the drug after other treatments had failed.

Both showed the drug was around 50 percent more effective at preventing relapses and patients had less disability at the end of the study than when they started.

"Although other MS drugs have emerged over the last year, which is certainly good news for patients, none has shown superior effects on disability when compared to interferon except alemtuzumab," Dr. Alasdair Coles, from the University of Cambridge says.

"It is certainly the most effective MS drug, based on these clinical trials, but this is definitely not a cure," he told reporters from the BBC.

The doctor warns that there were side-effects, including developing other immune disorders.

He said he thought the drug would be most useful for patients for whom standard treatment had failed and in a "minority" of patients as a first-choice drug.

The drug has been withdrawn from the market in both Europe and the United States as the manufacturer, Genzyme, intends to have it licensed as a treatment for MS.

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.

"Finding promising treatments such as alemtuzumab are important. But so is keeping alemtuzumab accessible and affordable."

.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2015
Universal:
That political responsibility may be lived at all levels as a high form of charity.
Evangelization: That, amid social inequalities, Latin American Christians may bear witness to love for the poor and contribute to a more fraternal society.



Comments


More Health

12,000 children may be exposed to HIV and Hepatitis from unsterile surgical equipment at hospital Watch

Image of The Seattle Children's Hospital is under controversy once again.

By Linky C. (NEWS CONSORTIUM)

Seattle's Bellevue clinic Children's Hospital contacts the parents of 12,000 children who might have been exposed to HIV and hepatitis due to un-sterile surgical equipment. MUNTINLUPA CITY, PHILIPPINES (Catholic Online) - Parents of roughly 12,000 children who were ... continue reading


High vaccination rates help protect communities Watch

Image of Pockets of unvaccinated people pose health risks to the immune-compromised population.

By Kenya Sinclair (NEWS CONSORTIUM)

Following the Disneyland Measles outbreak, more and more U.S. parents are vaccinating their children. Despite the increased number of "vaccinators," "anti-vaccers" pose a public health risk. LOS ANGELES, CA (Catholic Online) - The U.S. Centers for Disease Control and ... continue reading


The Universal Flu Vaccine: Researchers are closer to a solution that attacks a different part of the virus Watch

Image of Human immune response to influenza is directed against a protein on the virus called hemagglutinin, and a portion of the protein called the hemagglutinin head, where the majority of the mutations occur.

By Catholic Online (NEWS CONSORTIUM)

It's a universal misery that comes whenever the weather cools or it starts to rain. Influenza begins to settle in to a large part of the population, leading to school and job absences. Researchers now say hat attacking a largely hidden part of the influenza ... continue reading


Grandmother miraculously beats eight different cancers in a row Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Many people lose hope while battling cancer and experience even more trauma when they fight the same disease again and again. Despite the constant evolution of technology, there are still risks of developing different forms of cancer at any time. However, one ... continue reading


Hepatitis C finally given approval in United Kingdom after 'inexcusable wait' Watch

Image of Sufferer Pamela Anderson claims she got Hepatitis C from her ex-husband Tommy Lee after they shared tattoo needles.

By Catholic Online (NEWS CONSORTIUM)

It comes as wonderful news for untold thousands of Hepatitis C sufferers, albeit one that came after an "Inexcusable wait." The once-a-day drug sofosbuvir has a 90 percent success rate by patients - and will be available free of charge for patients in the ... continue reading


First human brain grown in laboratory dubbed success, despite scientific doubt Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

For the first time in the history of science, an almost full-grown human brain was successfully grown outside the body and in a laboratory by a team of researchers. According to The Guardian, the brain is a size comparable to that of a 5-week-old fetus. The brain will ... continue reading


Modern Paleo diet may not be so Paleolithic Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Carbohydrates, largely overlooked in the modern Paleo diet, were actually a part of the food group consumed by our hunting-and-gathering forefathers, according to a new study published earlier this month. Although the diet works effectively on some trying to lose ... continue reading


Is coffee really good for you? New research finds coffee may reduce risk of some cancers Watch

Image of

By Hannah Marfil (NEWS CONSORTIUM)

Caffeinated coffee drinkers are at a lower risk of having bowel cancer, as well as dying from the disease and other types, according to recent data. Those who drink four to five mugs of coffee a day were found to cut, by almost a half, the odds of bowel cancer ... continue reading


'Brainy' mice research may lead to effective treatment for Alzheimer's Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Genetically altered mice tend to be more intelligent and exhibit less anxiety, according to new research. The discovery is speculated to be a part of a more comprehensive study regarding treatment to diseases like Alzheimer's post-traumatic stress disorder (PTSD) and ... continue reading


Study finds intelligence related to a longer lifespan Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

A longer lifespan is related to intelligence contributed by the genetic makeup, according to new research. Analyzing three twin studies, a research team found that the link between intelligence and a person's life expectancy is about 95 percent because of genetics, ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Deuteronomy 4:1-2, 6-8
1 'And now, Israel, listen to the laws and customs ... Read More

Psalm, Psalms 15:2-3, 3-4, 4-5
2 Whoever lives blamelessly, who acts uprightly, who ... Read More

Gospel, Mark 7:1-8, 14-15, 21-23
1 The Pharisees and some of the scribes who had come ... Read More

Reading 2, James 1:17-18, 21-22, 27
17 all that is good, all that is perfect, is given us ... Read More

Saint of the Day

Saint of the Day for August 30th, 2015 Image

St. Rumon
August 30: St. Rumon, also known as Ruan, Ronan, and Ruadan, was probably a ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter